Life Sciences is in hyperdrive. The breakneck pace of innovation is saving millions of lives. Yet many challenges remain the same. How to balance the needs of patients and providers with the demands of regulators and stakeholders? How to lead with science while listening to human experience? Escalent’s deep healthcare and life sciences insights and agile implementation model help the innovators of today become the market leaders of tomorrow.
Escalent is a leading, global life sciences and healthcare market research and consulting firm. We know the players, the trends, and the policies that drive change across the health ecosystem. From big pharmaceutical companies to small biotech. From medical suppliers and device manufacturers to hospitals and healthcare providers.
The leaders of tomorrow need a holistic life sciences consulting partner. We support clients across the entire product lifecycle—from pre-clinical innovation to commercialization and post-launch tracking. You can expect seasoned medical consultants, data scientists, and insights practitioners with a passion for your industry. Let us help you accelerate the development process from molecule to brand launch and beyond.
Created for the pace and complexity of healthcare and life sciences, Escalent combines market intelligence, competitive insight, brand strategy and product innovation to help organizations meet patient and HCP needs and advance new treatments and technologies. We guide where to compete and how to focus innovation and build trusted healthcare brands that resonate with patients and HCPs. And with Managed Services executed by our implementation consultants, we seamlessly extend your team, accelerating execution and enabling confident, sustainable growth.
Show me moreIn an industry where decisions impact lives, our health and life sciences insights teams give health brand leaders the clarity they need. We apply expertise in data and analytics, behavioral science, qualitative and secondary research, human-guided AI, cultural intelligence and creative activation to uncover patient and HCP behaviors, helping brands create meaningful healthcare experiences and drive lasting impact across pharma, biotech, medtech and healthcare services.
Show me moreWith responsibly governed, human-guided AI applied by our certified experts, we help healthcare and life sciences organizations innovate responsibly, build trust and comply with evolving regulatory frameworks like the EU AI Act. This approach ensures patient and HCP insights are both actionable, transparent and ethically sound, supporting smarter decisions across research, commercialization and experience design.
Show me moreHealthcare and life sciences organizations are navigating rapid innovation while balancing regulatory complexity, patient expectations and commercialization pressures. Pharmaceutical, biotech and medical device companies must move new therapies from discovery to market faster while maintaining rigorous clinical and regulatory standards.
At the same time, patients, healthcare professionals and caregivers expect more transparent information, personalized treatment options and better digital experiences. Organizations increasingly rely on market insights and behavioral research to understand patient and provider needs across the product lifecycle—from early development to launch and post-market adoption—and the broader patient journey.
Patient-centricity is transforming how healthcare organizations develop treatments and design care experiences. Patients today expect to play a more active role in treatment decisions, access reliable information and receive therapies tailored to their individual needs.
This shift requires companies to understand patient experiences, treatment barriers and real-world outcomes more deeply. Research and behavioral insights help organizations identify unmet needs, improve communication with healthcare professionals and design therapies that better align with how patients manage their health in everyday life.
Digital technologies are changing how patients access care and how healthcare professionals stay informed about new treatments. AI, telehealth, wearable devices, digital therapeutics and remote monitoring tools are expanding the ways healthcare services are delivered and managed.
These innovations are also generating new streams of health data that can improve treatment insights and patient engagement. Organizations that successfully integrate digital tools with patient and provider insights are better positioned to improve care experiences and accelerate adoption of new therapies.
Artificial intelligence is increasingly shaping how healthcare organizations analyze data, identify trends and make strategic decisions across drug development, patient care and market access. AI tools can process large volumes of clinical, behavioral and healthcare utilization data to uncover insights that support faster and more informed decision-making, with privacy safeguards protecting sensitive patient information.
Synthetic data is also emerging as an important complement to AI analytics. By generating privacy-safe datasets that simulate real patient populations, synthetic data enables researchers to model treatment adoption, test hypotheses and explore complex healthcare scenarios while protecting sensitive health information.
Clinical success does not always translate into real-world adoption because treatments are evaluated differently outside controlled trial settings. While clinical trials focus on efficacy and safety, real-world use depends on how therapies fit into clinical workflows, patient lifestyles and long-term disease management.
Healthcare providers must balance evolving evidence with practical considerations, while patients face factors such as affordability, access and treatment burden. As a result, adoption is shaped by a combination of clinical, behavioral and system-level dynamics. Pharma companies that incorporate real-world insights into development and launch strategies are better positioned to close this gap.
AI is reshaping the patient journey, often before brands are even encountered. In a world where first impressions are generated, not delivered, understanding how information is interpreted is critical. See how healthcare teams are tracking evolving patient behavior and building trust.
MFN policies are moving faster than traditional pricing models can keep up. Find out how pharma teams can generate sharper insights, track global pricing shifts and make faster, more confident decisions in an uncertain market.
GLP-1 is moving faster than traditional research can keep up. See how pharma teams track real-world patient and HCP shifts, spot emerging signals and make sharper, faster decisions in a rapidly changing market.
Escalent launches a comprehensive behavioral science model powered by AI that produces better behavior change strategies faster.
Top data analytics and advisory firm Escalent announces it has acquired C Space and Hall & Partners.
Escalent's Tech TrustBuilder is a scientifically-validated framework that measures trust in technology to help brands build bonds with people
